HIV vaccine

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who’s hard at work on the holy grail of HIV research: a preventive treatment.

As the International AIDS Society Conference on HIV Science kicks off, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.

It’s been two years in the making, but the results of a pre-clinical study on an investigational therapy regimen are in. Co-author Hanneke Schuitemaker shares what researchers have learned.